Method of cardiac imaging with the use of hyperpolarized 13c-pyruvate

Mathilde Hauge Lerche (Inventor), Rene Zandt (Inventor), Klaes Golman (Inventor), Mikkel Thanning (Inventor), Jan Henrik Ardenkjær-Larsen (Inventor), Stefan Peterson (Inventor)

Research output: Patent

28 Downloads (Pure)


The invention relates to a method of cardiac imaging using hyperpolarised <13>C-pyruvate as MR imaging agent, which allows determination of the viability of cells in the myocardium.
Original languageEnglish
IPCA61K 49/ 06 A I
Patent numberEP1824523
Filing date29/08/2007
CountryInternational Bureau of the World Intellectual Property Organization (WIPO)
Priority date18/11/2005
Priority numberWO2005NO00434
Publication statusPublished - 29 Aug 2007
Externally publishedYes

Bibliographical note

Also published as:EP1824523 (B1) WO2006054903 (A2) WO2006054903 (A3) US2009162287 (A1) US8980224 (B2) RU2007118383 (A) RU2391047 (C2) MX2007006048 (A) KR20070089171 (A) KR101249634 (B1) JP2008520335 (A) JP5456256 (B2) ES2422558 (T3) CN101102799 (A) CN101102799 (B) CA2587795 (A1) CA2587795 (C) BRPI0518302 (A2) AU2005307194 (A1) AU2005307194 (B2)

Fingerprint Dive into the research topics of 'Method of cardiac imaging with the use of hyperpolarized 13c-pyruvate'. Together they form a unique fingerprint.

Cite this